CDT

0.0712

5.94% -0.0045

Handel nachbörslich: .07 -0.0012 -1.69%

Conduit Pharmaceuticals Inc (CDT)

Überblick Nachrichten Preisverlauf Warum fällt CDT? Forum Prognose

Schlusskurs vom Vortag:

$0.0757

Offen:

$0.0742

24-Stunden-Volumen:

10.91M

Relative Volume:

0.42

Marktkapitalisierung:

$8.53M

Einnahmen:

Nettoeinkommen (Verlust:

$-4.21M

KGV:

-1.2993

EPS:

-0.0548

Netto-Cashflow:

1W Leistung:

+18.47%

1M Leistung:

-26.52%

6M Leistung:

-88.88%

1J Leistung:

-98.48%

1-Tages-Spanne:

$0.07

$0.0769

1-Wochen-Bereich:

$0.0599

$0.0872

52-Wochen-Spanne:

$0.051

$5.29

Conduit Pharmaceuticals Inc Stock (CDT) Company Profile

Firmenname

Conduit Pharmaceuticals Inc

Sektor

Healthcare (1174)

Branche

Biotechnology (669)

Telefon

(646) 491 9132

Adresse

4851 TAMIAMI TRAIL NORTH, NAPLES

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CDT's Discussions on Twitter

Vergleichen Sie CDT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CDT Conduit Pharmaceuticals Inc	0.0712	8.53M	0	-4.21M	0	-0.0548
VRTX Vertex Pharmaceuticals Inc	407.11	104.84B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	718.15	78.92B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	621.29	37.15B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	234.28	30.22B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	115.79	27.76B	3.30B	-501.07M	1.03B	-2.1146

Conduit Pharmaceuticals Inc Aktie (CDT) Neueste Nachrichten

Dec 22, 2024

Stock Plummets to Cents. Can the Company Bounce Back? - Jomfruland.net

Dec 22, 2024

Dec 21, 2024

Conduit Pharmaceuticals faces Nasdaq delisting over price, votes for reverse split - Investing.com

Dec 21, 2024

Conduit Pharmaceuticals Faces Nasdaq Delisting, Plans Stock Split - TipRanks

Dec 21, 2024

Dec 12, 2024

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics - The Manila Times

Dec 12, 2024

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial - The Bakersfield Californian

Dec 12, 2024

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and - EIN News

Dec 12, 2024

Nov 26, 2024

Conduit Pharmaceuticals files to sell 75M shares of common stock for holders - MSN

Nov 26, 2024

Conduit Pharmaceuticals issues convertible note, amends Nirland agreement - Investing.com

Nov 26, 2024

Conduit Pharmaceuticals issues convertible note, amends Nirland agreement By Investing.com - Investing.com Canada

Nov 26, 2024

Nov 21, 2024

What's Going On With Conduit Pharmaceuticals Shares Today? - Benzinga

Nov 21, 2024

Stock market today: SCWorx Corp. gains 141.81% while Pyxis Oncology down by 46.41% in early trading - Business Upturn

Nov 21, 2024

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders - The Manila Times

Nov 21, 2024

Conduit Pharmaceuticals receives further patent approval for AZD1656 - TipRanks

Nov 21, 2024

Conduit Pharma Secures Key Patent for Autoimmune Drug AZD1656 in Major Japan Market | CDT Stock News - StockTitan

Nov 21, 2024

Nov 20, 2024

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Nov 20, 2024

Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - The Malaysian Reserve

Nov 20, 2024

Conduit Pharmaceuticals reshuffles board and amends bylaws - Investing.com

Nov 20, 2024

Conduit Pharmaceuticals reshuffles board and amends bylaws By Investing.com - Investing.com UK

Nov 20, 2024

Nov 19, 2024

Conduit Pharmaceuticals Announces Leadership Changes and Bylaws Update - TipRanks

Nov 19, 2024

Conduit Pharmaceuticals Strengthens Board with 30-Year Investment Banking Veteran Simon Fry | CDT Stock News - StockTitan

Nov 19, 2024

Nov 15, 2024

Conduit Pharmaceuticals announces restatement of financials - Investing.com

Nov 15, 2024

Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews

Nov 15, 2024

Nov 13, 2024

Remitly Global Inc (NASDAQ: RELY) Is The Number One Stock Currently Moving. - Stocks Register

Nov 13, 2024

Nov 11, 2024

Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews

Nov 11, 2024

Nov 05, 2024

Conduit Pharmaceuticals announces new addition to autoimmune pipeline - Yahoo Finance

Nov 05, 2024

Nov 04, 2024

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline - StockTitan

Nov 04, 2024

Nov 03, 2024

Conduit Pharmaceuticals Opens New Lab Space In Cambridge, UK - Contract Pharma

Nov 03, 2024

Nov 02, 2024

Conduit Pharmaceuticals secures $1.2 million in funding - Investing.com India

Nov 02, 2024

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes - The Manila Times

Nov 02, 2024

Nov 01, 2024

Conduit Pharmaceuticals secures $1.2 million in funding By Investing.com - Investing.com South Africa

Nov 01, 2024

Conduit Pharmaceuticals announces debt restructuring and additional notes - MSN

Nov 01, 2024

LeMaitre to Participate at Upcoming Investor Conferences in November - The Manila Times

Nov 01, 2024

Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements - TipRanks

Nov 01, 2024

Lexicon Pharmaceuticals Loses Over A Third Of Its Market Cap Post FDA Vote On Drug: Retail Sentiment Sours - MSN

Nov 01, 2024

Oct 30, 2024

Prologis Inc (NYSE: PLD): Forecast Strong In 2024, Up 18.49% - Stocks Register

Oct 30, 2024

Oct 22, 2024

Where Do Analysts Think The Conduit Pharmaceuticals Inc (NASDAQ: CDT) Is Going - Stocks Register

Oct 22, 2024

Oct 17, 2024

Presidio Property Trust Provides Update on Model Home Activity in Q3 2024 - The Manila Times

Oct 17, 2024

Oct 16, 2024

Conduit Pharmaceuticals announces debt restructuring By Investing.com - Investing.com Australia

Oct 16, 2024

Oct 15, 2024

Conduit Pharmaceuticals announces debt restructuring - Investing.com India

Oct 15, 2024

CDT Stock on the Rise: A Promising Investment - The InvestChronicle

Oct 15, 2024